IL6R and Hepatitis: Recent studies showed that IL-6-/- mice exhibited signs of liver inflammation [5], and when the IL-6R was deleted only in hepatocytes, mice developed liver inflammation, which could be reduced by Tnf-alpha blockade, suggesting a pivotal balance of IL-6 and Tnf-alpha signalling in the liver [43].